A detailed history of Mic Capital Management Uk LLP transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mic Capital Management Uk LLP holds 1,740,569 shares of LYEL stock, worth $1.74 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,740,569
Previous 1,740,569 -0.0%
Holding current value
$1.74 Million
Previous $2.52 Million 4.84%
% of portfolio
0.36%
Previous 0.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.45 - $3.35 $1.91 Million - $4.42 Million
-1,320,000 Reduced 43.13%
1,740,569 $2.56 Million
Q2 2022

Aug 15, 2022

BUY
$3.68 - $6.8 $6.41 Million - $11.8 Million
1,740,569 Added 131.86%
3,060,569 $20 Million
Q4 2021

Feb 14, 2022

BUY
$7.13 - $15.19 $9.41 Million - $20.1 Million
1,320,000 New
1,320,000 $10.2 Million

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $248M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Mic Capital Management Uk LLP Portfolio

Follow Mic Capital Management Uk LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mic Capital Management Uk LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mic Capital Management Uk LLP with notifications on news.